166 related articles for article (PubMed ID: 30467379)
1. Loss of Par3 promotes prostatic tumorigenesis by enhancing cell growth and changing cell division modes.
Zhou PJ; Wang X; An N; Wei L; Zhang L; Huang X; Zhu HH; Fang YX; Gao WQ
Oncogene; 2019 Mar; 38(12):2192-2205. PubMed ID: 30467379
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
[TBL] [Abstract][Full Text] [Related]
3. Lipid kinase PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1.
Le TPH; Nguyen NTT; Le DDT; Anwar MA; Lee SY
Cell Commun Signal; 2023 Jun; 21(1):149. PubMed ID: 37337213
[TBL] [Abstract][Full Text] [Related]
4. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.
Si Y; Ji X; Cao X; Dai X; Xu L; Zhao H; Guo X; Yan H; Zhang H; Zhu C; Zhou Q; Tang M; Xia Z; Li L; Cong YS; Ye S; Liang T; Feng XH; Zhao B
Cancer Res; 2017 Sep; 77(18):4868-4880. PubMed ID: 28754671
[TBL] [Abstract][Full Text] [Related]
5. Dual function of partitioning-defective 3 in the regulation of YAP phosphorylation and activation.
Zhang P; Wang S; Wang S; Qiao J; Zhang L; Zhang Z; Chen Z
Cell Discov; 2016; 2():16021. PubMed ID: 27462467
[TBL] [Abstract][Full Text] [Related]
6.
Nantie LB; Young RE; Paltzer WG; Zhang Y; Johnson RL; Verheyden JM; Sun X
Development; 2018 Nov; 145(21):. PubMed ID: 30305289
[TBL] [Abstract][Full Text] [Related]
7. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.
Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS
Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470
[TBL] [Abstract][Full Text] [Related]
8. N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability.
Yabuta N; Mukai S; Okamoto A; Okuzaki D; Suzuki H; Torigata K; Yoshida K; Okada N; Miura D; Ito A; Ikawa M; Okabe M; Nojima H
J Cell Sci; 2013 Jan; 126(Pt 2):508-20. PubMed ID: 23230145
[TBL] [Abstract][Full Text] [Related]
9. FFAR1-and FFAR4-dependent activation of Hippo pathway mediates DHA-induced apoptosis of androgen-independent prostate cancer cells.
Wang J; Hong Y; Shao S; Zhang K; Hong W
Biochem Biophys Res Commun; 2018 Nov; 506(3):590-596. PubMed ID: 30366669
[TBL] [Abstract][Full Text] [Related]
10. Crumbs3-Mediated Polarity Directs Airway Epithelial Cell Fate through the Hippo Pathway Effector Yap.
Szymaniak AD; Mahoney JE; Cardoso WV; Varelas X
Dev Cell; 2015 Aug; 34(3):283-96. PubMed ID: 26235047
[TBL] [Abstract][Full Text] [Related]
11. The signaling adaptor GAB1 regulates cell polarity by acting as a PAR protein scaffold.
Yang Z; Xue B; Umitsu M; Ikura M; Muthuswamy SK; Neel BG
Mol Cell; 2012 Aug; 47(3):469-83. PubMed ID: 22883624
[TBL] [Abstract][Full Text] [Related]
12. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
13. Rassf5 and Ndr kinases regulate neuronal polarity through Par3 phosphorylation in a novel pathway.
Yang R; Kong E; Jin J; Hergovich A; Püschel AW
J Cell Sci; 2014 Aug; 127(Pt 16):3463-76. PubMed ID: 24928906
[TBL] [Abstract][Full Text] [Related]
14. Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP.
Chen Q; Zhang N; Xie R; Wang W; Cai J; Choi KS; David KK; Huang B; Yabuta N; Nojima H; Anders RA; Pan D
Genes Dev; 2015 Jun; 29(12):1285-97. PubMed ID: 26109051
[TBL] [Abstract][Full Text] [Related]
15. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.
Han Y; Tang Z; Zhao Y; Li Q; Wang E
Mol Carcinog; 2018 Feb; 57(2):159-166. PubMed ID: 28926138
[TBL] [Abstract][Full Text] [Related]
16. Shp2 promotes metastasis of prostate cancer by attenuating the PAR3/PAR6/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition.
Zhang K; Zhao H; Ji Z; Zhang C; Zhou P; Wang L; Chen Q; Wang J; Zhang P; Chen Z; Zhu HH; Gao WQ
Oncogene; 2016 Mar; 35(10):1271-82. PubMed ID: 26050620
[TBL] [Abstract][Full Text] [Related]
17. YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function.
Tsutsumi R; Masoudi M; Takahashi A; Fujii Y; Hayashi T; Kikuchi I; Satou Y; Taira M; Hatakeyama M
Dev Cell; 2013 Sep; 26(6):658-65. PubMed ID: 24035415
[TBL] [Abstract][Full Text] [Related]
18. Dual function of Yap in the regulation of lens progenitor cells and cellular polarity.
Song JY; Park R; Kim JY; Hughes L; Lu L; Kim S; Johnson RL; Cho SH
Dev Biol; 2014 Feb; 386(2):281-90. PubMed ID: 24384391
[TBL] [Abstract][Full Text] [Related]
19. Two faces of Hippo: activate or suppress the Hippo pathway in cancer.
Cao J; Huang W
Anticancer Drugs; 2017 Nov; 28(10):1079-1085. PubMed ID: 28926422
[TBL] [Abstract][Full Text] [Related]
20. Neddylation mediates ventricular chamber maturation through repression of Hippo signaling.
Zou J; Ma W; Li J; Littlejohn R; Zhou H; Kim IM; Fulton DJR; Chen W; Weintraub NL; Zhou J; Su H
Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E4101-E4110. PubMed ID: 29632206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
